Quick Answer
Bioventus Inc. reported Stockholders Equity of $184.10 million for fiscal year 2025.
Bioventus Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $184.10M | +24.4% |
| 2024 | $147.94M | -14.8% |
| 2023 | $173.59M | -46.6% |
| 2022 | $325.24M | -29.1% |
| 2021 | $458.92M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $166.10M | +11.7% | +3.0% |
| June 30, 2025 | $161.24M | +6.8% | +8.8% |
| March 31, 2025 | $148.14M | -13.5% | +0.1% |
| December 31, 2024 | $147.94M | -14.8% | -0.5% |
| September 30, 2024 | $148.74M | -16.2% | -1.5% |
| June 30, 2024 | $150.94M | -17.6% | -11.9% |
| March 31, 2024 | $171.28M | -9.1% | -1.3% |
| December 31, 2023 | $173.59M | -46.6% | -2.2% |
- Bioventus Inc. showed an increase of +24.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2021–2025 period, Bioventus Inc.’s stockholders equity has declined by 59.9% (from $458.92 million to $184.10 million).
- The most recent figure is from Bioventus Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: